Skip to main content
. 2017 Jun;6(3):144–153. doi: 10.21037/hbsn.2016.08.06

Figure 2.

Figure 2

Comparison of the Kaplan-Meier survival curves of re-explored patients receiving neoadjuvant therapy (n=37; dotted line) and no-neoadjuvant therapy (n=13; full line). A log-rank test demonstrated neoadjuvant therapy was associated with improved survival (P=0.044).